Suppr超能文献

氯硝西泮治疗惊恐障碍和广场恐惧症:一年随访

Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up.

作者信息

Pollack M H, Tesar G E, Rosenbaum J F, Spier S A

出版信息

J Clin Psychopharmacol. 1986 Oct;6(5):302-4.

PMID:3771814
Abstract

Fifty patients with panic disorder or agoraphobia with panic attacks with treated with clonazepam, a high potency benzodiazepine. The authors report on the outcome of these patients after an average follow-up interval of 1 year, suggesting that clonazepam is a safe, effective, and easy to administer medication in a relatively treatment-refractory population of nondepressed patients with panic disorder and agoraphobia.

摘要

五十名患有惊恐障碍或伴有惊恐发作的广场恐惧症患者接受了高效苯二氮䓬类药物氯硝西泮的治疗。作者报告了这些患者在平均随访1年后的结果,表明氯硝西泮在患有惊恐障碍和广场恐惧症的非抑郁且相对难治的患者群体中是一种安全、有效且易于给药的药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验